Summary of week 1

In this week, you have learnt that:

• AMR remains a political and public health priority, but challenges remain, including globally harmonised targets to monitor progress, collaboration between sectors, and sustained funding
• COVID-19 has impacted the AMR response, and will continue to do so, such as overuse of antibiotics, disruptions to health care and immunization services
• The COVID-19 pandemic has brought us potential positive impacts such as new technological innovations in diagnostics, real time data capture and strengthened surveillance. These advances may be leveraged to build a more responsive AMR programme.

Next week we will learn about the latest resistance trends and what new technologies can be used in the management of common clinical syndromes, tuberculosis and gonorrhoea.

The activities for week 2 are available to view now, but if you decide to view them early you may want to return to the comments and discussions while the week is live to see the perspectives of other learners and to offer your own.

At the end of each week, we collate the key thoughts, themes, and any questions from your discussions into a summary document added to the Downloads section at the bottom of this page.